Weekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe episode artwork

EPISODE · Sep 4, 2024 · 4 MIN

Weekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe

from Eyewire News: The Podcast · host Eyewire News

First Therapy for Acanthamoeba Keratitis Approved in Europe • Oculus Adds Dual Testing Functionality to Easyfield VR • FDA Clears IND Application for Stem Cell Therapy for Primary Photoreceptor Diseases Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

Weekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe

0:00 4:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 4 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on September 4, 2024.

What is this episode about?

First Therapy for Acanthamoeba Keratitis Approved in Europe • Oculus Adds Dual Testing Functionality to Easyfield VR • FDA Clears IND Application for Stem Cell Therapy for Primary Photoreceptor Diseases Learn more about your ad choices. Visit...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!